Hong Kong · Delayed Price · Currency is HKD Shenzhen Edge Medical Statistics
Total Valuation
HKG:2675 has a market cap or net worth of HKD 13.99 billion. The enterprise value is 11.97 billion.
| Market Cap | 13.99B |
| Enterprise Value | 11.97B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2675 has 391.88 million shares outstanding. The number of shares has increased by 4.14% in one year.
| Current Share Class | 327.76M |
| Shares Outstanding | 391.88M |
| Shares Change (YoY) | +4.14% |
| Shares Change (QoQ) | +8.28% |
| Owned by Insiders (%) | 39.87% |
| Owned by Institutions (%) | 13.87% |
| Float | 150.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 76.72 |
| PS Ratio | 19.37 |
| PB Ratio | 5.25 |
| P/TBV Ratio | 5.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 16.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.49, with a Debt / Equity ratio of 0.02.
| Current Ratio | 19.49 |
| Quick Ratio | 17.03 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 1.40 |
| Debt / FCF | n/a |
| Interest Coverage | 13.50 |
Financial Efficiency
Return on equity (ROE) is -1.07% and return on invested capital (ROIC) is 0.40%.
| Return on Equity (ROE) | -1.07% |
| Return on Assets (ROA) | 0.38% |
| Return on Invested Capital (ROIC) | 0.40% |
| Return on Capital Employed (ROCE) | 0.49% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.20M |
| Profits Per Employee | -35,884 |
| Employee Count | 604 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.80 |
Taxes
| Income Tax | -25,398 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 37.76 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.30 |
| Average Volume (20 Days) | 339,686 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2675 had revenue of HKD 722.29 million and -21.67 million in losses. Loss per share was -0.06.
| Revenue | 722.29M |
| Gross Profit | 474.98M |
| Operating Income | 13.23M |
| Pretax Income | -21.70M |
| Net Income | -21.67M |
| EBITDA | 35.41M |
| EBIT | 13.23M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 2.07 billion in cash and 49.42 million in debt, with a net cash position of 2.03 billion or 5.17 per share.
| Cash & Cash Equivalents | 2.07B |
| Total Debt | 49.42M |
| Net Cash | 2.03B |
| Net Cash Per Share | 5.17 |
| Equity (Book Value) | 2.67B |
| Book Value Per Share | 6.80 |
| Working Capital | 2.58B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 22.45M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 65.76%, with operating and profit margins of 1.83% and -3.00%.
| Gross Margin | 65.76% |
| Operating Margin | 1.83% |
| Pretax Margin | -3.00% |
| Profit Margin | -3.00% |
| EBITDA Margin | 4.90% |
| EBIT Margin | 1.83% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2675 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.14% |
| Shareholder Yield | -4.14% |
| Earnings Yield | -0.15% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for HKG:2675 is 72.00, which is 101.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 72.00 |
| Price Target Difference | 101.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 64.58% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |